Knowasiak Community


Body issues - Featured - July 11, 2020

COVAXIN can’t become public before 2021 – India

Officials said, that people must wait till 2021 first quarter in order to get vaccine working and get all healed. According to them this is the shortest possible time to get vaccine practically ready.  The news comes days after the Parliamentary standing committees had begun to resume work after a long spell of hibernation.

COVAXIN can’t become public before 2021 – India

Covaxin or COVID – 19 Vaccine is going to be developed by Government’s Medical Research body, Indian Council of Medical Research (ICMR). They targeted to get the vaccine working by 15th of august, however now it had to be delayed for practical use.

Indian Government’s Principal Scientific Advisor – Professor Krishnaswamy VijayRaghavan, was present in the meeting. Representatives of Council of Scientific and Industrial Research (CSIR), the Department of Science and Technology and the Department of Biotechnology were also present.

Subscribe to newsletter and get updates delivered to your Inbox!

ICMR clarified that, “it was all, meant to cut unnecessary red tape, without bypassing any necessary process, and speed up recruitment of participants”.

Members of committe were believed to have raised specific questions about recent claims made by yoga guru Ramdev who launched Coronil, claiming it can treat coronavirus, only to retract later.

Meanwhile, researchers in India are all set to start human trials of India’s first indigenous coronavirus vaccine candidate – COVAXIN.

Seniors & Officials at the comitee told that they are  hopeful and optimistic about India’s chances of inventing the vaccine that will be able to treat Corona Virus. This Committee was led by Congress MP Jairam Ramesh.

Bharat Biotech MD Dr Krishna Ella, tells Times Now Digital why he believes COVAXIN, India’s first indigenous coronavirus vaccine, created by the firm will work against the SARS-CoV-2

Hyderabad: Earlier this week, COVAXIN developed by leading vaccine maker Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology (NIV), became India’s first indigenous vaccine against the novel coronavirus now called the SARS-CoV-2 to get the approval for human clinical trials from the drug regulator. The Hyderabad-based biotech firm has been given the go-ahead by the DCGI to conduct phase 1 and 2 clinical trials of its COVID-19 vaccine candidate after preclinical studies demonstrated safety and effective immune response.


Top Badges To Earn

Platinum Cup

Won an official Social Network competition

Silver User

Has posted more than 100 posts on their profile

1 Required Step

  • Write an activity stream message 100 times

Gold User

Has posted more than 500 posts on their profile

1 Required Step

  • Write an activity stream message 500 times

Platinum User

Has posted more than 1000 posts on their profile

1 Required Step

  • Write an activity stream message 1000 times

Mightier Than Sword

Successfully published at least 10 blog posts

1 Required Step

  • Publish a new post 10 times

Caffeinated Readers

Received more than 500 daily visits on any post

1 Required Step

  • Daily visit any post 500 times





We would like to show you notifications for the latest news and updates.
Allow Notifications